HALO
HALO
NASDAQ · Biotechnology

Halozyme Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$68.99
+0.44 (+0.64%)
Analyst Consensus
Buy
16
Analysts
High
Coverage
Buy 11 69%
Hold 4 25%
Sell 1 6%
Price Target
Analyst Price Target -69.5% upside
Low Target $15.29
Average Target $21.02
High Target $24.22
Current Price $68.99
Current
$68.99
Target
$21.02
$15.29 $21.02 avg $24.22
Scenario Analysis
Bear Case
$15.29
-77.8%
Low target
Base Case
$21.02
-69.5%
Avg target
Bull Case
$24.22
+-64.9%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$82.22
-16.1% from high
52-Week Low
$51.06
+35.1% from low
50-Day SMA
$71.23
-3.1% vs SMA
200-Day SMA
$65.75
+4.9% vs SMA
RSI (14)
47.6
Neutral
Target vs 52W High
$21.02
-74.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%